ArticleThe Lancet regional health. Southeast Asia2026
Household SARS-CoV-2 transmission during Omicron wave in Chiang Mai, Thailand: a prospective observational study.
Article in The Lancet regional health. Southeast Asia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: SARS-CoV-2 transmission studies involving children in Thailand have been relatively limited to the early waves with the alpha and delta variants. Our study aims to address these gaps by examining household transmission in Chiang Mai, northern Thailand, during the Omicron wave in a post vaccination period. Methods: This prospective observational study enrolled households comprising a confirmed COVID-19 index patient with at least one uninfected contact and a child (<18 years of age who maybe an index or contact). Participant data, nasopharyngeal swabs, and blood samples were collected at entry and final visit. Participants recorded daily symptoms for 21 days and self-administered SARS-CoV-2 antigen tests every other day for 14 days. Incident infections were confirmed by RT-PCR. Secondary attack rates (SARs) were calculated and associated factors were analyzed using multivariable generalized estimating equations models. Phylogenetic analysis was used to confirm intra-household transmission. Findings: From July 2022 to May 2024, 93 households (93 index cases, 197 contacts) were enrolled; 52% of index cases and 49% of contacts were <18 years. Among contacts, despite 89% (175/197) having received the SARS-CoV-2 vaccine (of whom 75% > 6 months prior), 44 became infected, yielding a household SAR of 33% (95% CI: 24-44). In phylogenetically-confirmed transmission, SAR was 25% (95% CI: 17-35). Index low viral load (aRR: 0.82, 95% CI: 0.74-0.92) and contacts baseline anti-NCP IgG positivity (aRR: 0.42, 95% CI: 0.22-0.83) were significantly associated with lower household transmission. Interpretation: Despite widespread vaccination, household transmission of SARS-CoV-2 remained common. Prior immunity in contacts and lower viral load in index cases reduced risk. These findings underscore the central role of households in ongoing spread and highlight the value of booster vaccination and genomic surveillance to clarify transmission pathways and inform prevention policies. Funding: The study was funded by the European Health and Digital Executive Agency (HADEA), European Commission, and by the Institut de Recherche pour le Développement (IRD), France.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.